FDA
approval
· 2012-07-31
FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for ALYACEN 1/35, a generic combined oral contraceptive containing norethindrone and ethinyl estradiol, manufactured by …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ALYACEN 1/35 (NORETHINDRONE AND ETHINYL ESTRADIOL)